While RUNX1 mutations are considered rather rare in BPDCN we observed eleven cases, however, most of these (nine out of eleven) where these mutations were subclonal events and some cases even exhibited syn- and/or metachronous myeloid neoplasms other than BPDCN. The gene discussed is RUNX1; the disease is myeloid neoplasm.